2020-11-20 04:28
(7 d 08:16 ago)

Posting: # 22071
Views: 144

 Regarding Steady state study in BE studies [Design Issues]


Usually steady state techniques are conducted to maintain constant free drug in plasma with equal elimination. It applies for drugs which come under Time dependent activity.

My question,

1. In what case or particular class of drugs we should go for steady state studies in comparitive BA or BE studies?

2. How does Vidagliptin/metformin (fdc) comes under steady state studies?

Appreciating in advance for your response.

Thank you.

With warm regards,
T. Vijith
 Admin contact
21,213 posts in 4,426 threads, 1,481 registered users;
online 24 (0 registered, 24 guests [including 15 identified bots]).
Forum time: Friday 12:44 CET (Europe/Vienna)

Biostatistician. One who has neither the intellect for mathematics
nor the commitment for medicine but likes to dabble in both.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz